SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-06-019822
Filing Date
2006-02-03
Accepted
2006-02-03 17:06:17
Documents
2
Period of Report
2006-02-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 13896
2 CHELSEA THERAPEUTICS, INC. 2004 STOCK PLAN, AS AMENDED FEBRUARY 1, 2006 dex104.htm EX-10.4 144241
  Complete submission text file 0001193125-06-019822.txt   159742
Mailing Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277
Business Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51462 | Film No.: 06578729
SIC: 2836 Biological Products, (No Diagnostic Substances)